FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin

The FDA concluded that the type 2 diabetes medicine canagliflozin causes an increased risk of leg and foot amputations.
ReachMD Healthcare Image
Media formats available
  • Completing the pre-test is required to access this content.
    Pre-Survey
    Completing the pre-survey is required to access this content.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free